Plasma anti-diabetic NUCB2 peptide (pladin) and uses thereof
US8541367B2 · kind B2 · utility
0Cited by
1References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 12, 2010 |
| Grant date | Sep 24, 2013 |
| Priority date | — |
| Expiry date | Sep 20, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/042
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides pladin (plasma anti-diabetic nucb2 peptide) polypeptide and functional equivalent thereof that are useful for treating diabetes. The present invention provides a method of treating diabetes by administering to a subject nesfatin-1, pladin, or a functional equivalent thereof. The present invention also provides a method of treating diabetes by administering to subject plasmin inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.